- Home
- MVIS vs PRQR Comparison
MVIS vs PRQR Comparison
Compare MVIS & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MVIS | PRQR |
|---|---|---|
| Founded | 1993 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.6M | 244.1M |
| IPO Year | 2010 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MVIS | PRQR |
|---|---|---|
| Price | $0.30 | $1.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $2.25 | ★ $7.25 |
| AVG Volume (30 Days) | ★ 11.4M | 1.6M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $664,000.00 | N/A |
| Revenue This Year | $529.06 | N/A |
| Revenue Next Year | $168.46 | $13.92 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.26 | $1.33 |
| 52 Week High | $1.73 | $3.10 |
Technical Indicators
Market Signals| Indicator | MVIS | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 35.87 | 51.27 |
| Support Level | $0.26 | $1.40 |
| Resistance Level | $0.42 | $1.99 |
| Average True Range (ATR) | 0.05 | 0.15 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 21.42 | 45.98 |
Price Performance
Historical ComparisonAbout MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars. Geographically, the company operates in United States, Germany, and Other foreign countries.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.